Argentina Meningococcal Vaccines Market Size & Outlook
Global Market
Related Markets
Argentina meningococcal vaccines market highlights
- The Argentina meningococcal vaccines market generated a revenue of USD 43.8 million in 2025 and is expected to reach USD 74.6 million by 2033.
- The Argentina market is expected to grow at a CAGR of 6.3% from 2026 to 2033.
- In terms of segment, menveo was the largest revenue generating brand in 2025.
- Nimenrix is the most lucrative brand segment registering the fastest growth during the forecast period.
Meningococcal vaccines market data book summary
| Market revenue in 2025 | USD 43.8 million |
| Market revenue in 2033 | USD 74.6 million |
| Growth rate | 6.3% (CAGR from 2026 to 2033) |
| Largest segment | Menveo |
| Fastest growing segment | Nimenrix |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Menactra, Menveo, Nimenrix, Trumenba, Bexsero |
| Key market players worldwide | Pfizer Inc, Sanofi SA, GSK PLC, Merck & Co Inc, Serum Institute of India Pvt. Ltd., Walvax Biotechnology |
Other key industry trends
- In terms of revenue, Argentina accounted for 1.1% of the global meningococcal vaccines market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Latin America, Argentina meningococcal vaccines market is projected to lead the regional market in terms of revenue in 2033.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 74.6 million by 2033.
In Argentina, serogroup B and W are responsible for majority of IMD cases. According to a study published by NCBI in 2019, the number of IMD cases and deaths due to it were expected to be 3.1 and 1.9 times higher than reported. This shows lack of availability of diagnostic tools, infrastructure, and awareness.
Hence, there remains a high unmet need for vaccination in the country. Increase in government initiatives coupled with high incidence of meningitis is expected to drive the market over the forecast period. For instance, in Argentina, more than 500 cases of bacterial meningitis are reported every year.
Furthermore, presence of key players such as Sanofi, Pfizer, and GlaxoSmithKline is expected to drive the market. An increase in the healthcare expenditure per capita by 9.12% is expected to drive the market over the forecast period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Meningococcal Vaccines Market Scope
Meningococcal Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Pfizer Inc | View profile | 88,000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | www.pfizer.com |
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| Merck & Co Inc | View profile | 72,000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | www.merck.com |
| GSK PLC | View profile | 70,200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | www.gsk.com |
| Serum Institute of India Pvt. Ltd. | View profile | 1001-5000 | Pune, Maharashtra, India, Asia | www.seruminstitute.com/ |
| Walvax Biotechnology | View profile | 11-50 | Kunming, Yunnan, China, Asia | www.walvax.com |
Argentina Meningococcal Vaccines Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Meningococcal Vaccines Market Outlook will help companies and investors design strategic landscapes.
Menveo was the largest segment with a revenue share of 33.11% in 2025.
Horizon Databook has segmented the Argentina meningococcal vaccines market based on menactra, menveo, nimenrix, trumenba, bexsero covering the revenue growth of each sub-segment from 2021 to 2033.
In Argentina, serogroup B and W are responsible for majority of IMD cases. According to a study published by NCBI in 2019, the number of IMD cases and deaths due to it were expected to be 3.1 and 1.9 times higher than reported. This shows lack of availability of diagnostic tools, infrastructure, and awareness.
Hence, there remains a high unmet need for vaccination in the country. Increase in government initiatives coupled with high incidence of meningitis is expected to drive the market over the forecast period. For instance, in Argentina, more than 500 cases of bacterial meningitis are reported every year.
Furthermore, presence of key players such as Sanofi, Pfizer, and GlaxoSmithKline is expected to drive the market. An increase in the healthcare expenditure per capita by 9.12% is expected to drive the market over the forecast period.
- Argentina Meningococcal Vaccines Market Brand Outlook (Revenue, USD Million , 2021-2033)
- Menactra
- Menveo
- Nimenrix
- Trumenba
- Bexsero
- Others
- Argentina Meningococcal Vaccines Market Serotype Outlook (Revenue, USD Million , 2021-2033)
- A
- B
- C
- W-135
- Y
- Argentina Meningococcal Vaccines Market Age Group Outlook (Revenue, USD Million , 2021-2033)
- Infants (0 to 2 years)
- Children and Adults (2 years and above)
- Argentina Meningococcal Vaccines Market Sales Channel Outlook (Revenue, USD Million , 2021-2033)
- Private
- Public
- Argentina Meningococcal Vaccines Market Type Outlook (Revenue, USD Million , 2021-2033)
- Bivalent
- Quadrivalent
- Others
Reasons to subscribe to Meningococcal Vaccines Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Meningococcal Vaccines Market Outlook databook
- Our clientele includes a mix of Meningococcal Vaccines Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina Meningococcal Vaccines Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Argentina Meningococcal Vaccines Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Argentina Meningococcal Vaccines Market, 2021-2033 (US$M)
Argentina Brand - Meningococcal Vaccines Market Statistics, 2025 - 2033 (US$M)
